Literature DB >> 6884418

The binding of ketamine to plasma proteins: emphasis on human plasma.

P G Dayton, R L Stiller, D R Cook, J M Perel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6884418     DOI： 10.1007/bf00607095

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  34 in total

1.  Interaction between sedative premedicants and ketamine in man in isolated perfused rat livers.

Authors:  J N Lo; J F Cumming
Journal:  Anesthesiology       Date:  1975-09       Impact factor: 7.892

2.  The fate of thiopental in man and a method for its estimation in biological material.

Authors:  B B BRODIE; L C MARK
Journal:  J Pharmacol Exp Ther       Date:  1950-01       Impact factor: 4.030

3.  Binding of psychotropic drugs to isolated alpha-acid glycoprotein.

Authors:  M L Kornguth; L G Hutchins; B S Eichelman
Journal:  Biochem Pharmacol       Date:  1981-09-01       Impact factor: 5.858

4.  Study of ketamine as an obstetric anesthetic agent.

Authors:  B Little; T Chang; L Chucot; W A Dill; L L Enrile; A J Glazko; M Jassani; H Kretchmer; A Y Sweet
Journal:  Am J Obstet Gynecol       Date:  1972-05-15       Impact factor: 8.661

5.  A comparison of the binding of drugs to adult and cord plasma.

Authors:  A W Pruitt; P G Dayton
Journal:  Eur J Clin Pharmacol       Date:  1971-12       Impact factor: 2.953

6.  Pharmacology of ketamine isomers in surgical patients.

Authors:  P F White; J Ham; W L Way; A J Trevor
Journal:  Anesthesiology       Date:  1980-03       Impact factor: 7.892

7.  Changes in plasma drug binding and alpha 1-acid glycoprotein in mother and newborn infant.

Authors:  M Wood; A J Wood
Journal:  Clin Pharmacol Ther       Date:  1981-04       Impact factor: 6.875

8.  Meperidine binding in maternal and fetal plasma.

Authors:  R L Nation
Journal:  Clin Pharmacol Ther       Date:  1981-04       Impact factor: 6.875

9.  Plasma protein binding of phencyclidine.

Authors:  H G Giles; W A Corrigall; V Khouw; E M Sellers
Journal:  Clin Pharmacol Ther       Date:  1982-01       Impact factor: 6.875

10.  Studies on the biotransformation of ketamine. 1-Identification of metabolites produced in vitro from rat liver microsomal preparations.

Authors:  J D Adams; T A Baillie; A J Trevor; N Castagnoli
Journal:  Biomed Mass Spectrom       Date:  1981-11
View more
  16 in total

1.  Propofol increases the rate of albumin-unbound free midazolam in serum albumin solution.

Authors:  Jun Ohmori; Shigeru Maeda; Hitoshi Higuchi; Minako Ishii; Yukiko Arai; Yumiko Tomoyasu; Atsushi Kohjitani; Masahiko Shimada; Takuya Miyawaki
Journal:  J Anesth       Date:  2011-06-01       Impact factor: 2.078

Review 2.  Stereoselectivity in clinical pharmacokinetics and drug development.

Authors:  D B Campbell
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Apr-Jun       Impact factor: 2.441

3.  Pharmacokinetic comparison between the long-term anesthetized, short-term anesthetized and conscious rat models in nasal drug delivery.

Authors:  Yin Cheong Wong; Shuai Qian; Zhong Zuo
Journal:  Pharm Res       Date:  2014-02-20       Impact factor: 4.200

Review 4.  Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.

Authors:  Panos Zanos; Ruin Moaddel; Patrick J Morris; Lace M Riggs; Jaclyn N Highland; Polymnia Georgiou; Edna F R Pereira; Edson X Albuquerque; Craig J Thomas; Carlos A Zarate; Todd D Gould
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

5.  Ketamine induction for a patient with hyperinsulinism treated with oral diazoxide.

Authors:  M Yamashita; K Motokawa; T Hirano
Journal:  Can Anaesth Soc J       Date:  1986-09

6.  Effects of enzyme induction, renal and cardiac function on ketamine plasma kinetics in patients with ketamine long-term analgosedation.

Authors:  C Köppel; I Arndt; K Ibe
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Jul-Sep       Impact factor: 2.441

Review 7.  Expanding Role of NMDA Receptor Antagonists in the Management of Pain.

Authors:  Denise Kreutzwiser; Qutaiba A Tawfic
Journal:  CNS Drugs       Date:  2019-04       Impact factor: 5.749

8.  CYP2B6*6 allele and age substantially reduce steady-state ketamine clearance in chronic pain patients: impact on adverse effects.

Authors:  Yibai Li; Kate A Jackson; Barry Slon; Janet R Hardy; Michael Franco; Leeroy William; Peter Poon; Janet K Coller; Mark R Hutchinson; David C Currow; Andrew A Somogyi
Journal:  Br J Clin Pharmacol       Date:  2015-06-01       Impact factor: 4.335

Review 9.  Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy.

Authors:  Marko A Peltoniemi; Nora M Hagelberg; Klaus T Olkkola; Teijo I Saari
Journal:  Clin Pharmacokinet       Date:  2016-09       Impact factor: 6.447

10.  Ketamine attenuates the Na+-dependent Ca2+ overload in rabbit ventricular myocytes in vitro by inhibiting late Na+ and L-type Ca2+ currents.

Authors:  An-tao Luo; Zhen-zhen Cao; Yu Xiang; Shuo Zhang; Chun-ping Qian; Chen Fu; Pei-hua Zhang; Ji-hua Ma
Journal:  Acta Pharmacol Sin       Date:  2015-10-12       Impact factor: 6.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.